Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HNRG | CEG |
|---|---|---|
| Price | $13.65 | $299.59 |
| Change today | ▼ 7.83% | ▼ 0.27% |
| Market cap | $643.51M | $106.15B |
| Return, 3 months | -17.5% | +19.7% |
| Return, year to date | -28.3% | -14.8% |
| Return, 1 year | -31.1% | -18.8% |
| P/E (TTM) | 682.5 | 29.3 |
| P/B | 3.4 | 3.3 |
| P/E percentile vs own 5y | 97th | 46th |
| Dividend yield | – | 0.54% |
| Revenue growth (YoY, latest qtr) | -1.3% | +23.0% |
| Net profit growth (YoY) | -284.7% | -39.0% |
| Gross margin | 47.3% | 21.4% |
| Operating margin | 3.2% | 17.8% |
| Net margin | -0.2% | 11.1% |
| Return on equity | -0.6% | 15.3% |
| Analyst target vs. price | +101.5% | +17.8% |
| Analyst buy share | 100% | 88% |
| RSI (14) | 40 | 67 |
| 30-day volatility | 47.7% | 51.6% |
| Max drawdown, 1 year | -43.3% | -41.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
